Chimera Investment Corp (CIM) CEO Kardis Acquires 101,772 Shares via PSU Vesting

Rhea-AI Filing Summary

Chimera Investment Corporation reported an insider equity transaction by President, CEO, and Director Phillip John Kardis II. On 12/18/2025, he acquired 101,772 shares of Chimera common stock at a stated price of $0, reflecting the vesting of performance stock units and associated dividend equivalent rights. Each performance stock unit and each dividend equivalent right is the economic equivalent of one share of Chimera common stock.

Following this vesting event, Kardis beneficially owns 500,721 shares of Chimera common stock in direct form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kardis Phillip John II

(Last) (First) (Middle)

C/O: CHIMERA INVESTMENT CORPORATION

630 FIFTH AVENUE, SUITE 2400

(Street)

NEW YORK NY 10111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHIMERA INVESTMENT CORP [ CIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/18/2025		A		101,772(1)	A	$0	500,721(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vesting of shares of Chimera Investment Corporation ("Chimera") common stock underlying performance stock units ("PSUs") and the dividend equivalent rights ("DERs") accrued on such PSUs since the grant date. Each PSU is the economic equivalent of one share of Chimera common stock.

2. DERs issued on Restricted Stock Units or RSUs and PSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Remarks:

	/s/ Phillip John Kardis II	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chimera Investment Corp (CIM) report?

Chimera Investment Corp reported that President, CEO, and Director Phillip John Kardis II acquired 101,772 shares of common stock on 12/18/2025 at a stated price of $0.

Why did Phillip John Kardis II receive 101,772 CIM shares?

The 101,772 shares represent the vesting of Chimera common stock underlying performance stock units (PSUs) and the related dividend equivalent rights (DERs) accrued since the grant date.

How many CIM shares does the reporting person own after this transaction?

After the reported transaction, Phillip John Kardis II beneficially owns 500,721 shares of Chimera Investment Corporation common stock in direct ownership.

What are PSUs and DERs in this Chimera Investment Corp (CIM) filing?

Each PSU is the economic equivalent of one share of Chimera common stock, and each DER is also the economic equivalent of one share, with DERs issued on RSUs and PSUs included in the reporting person’s common stock balance.

Is the reported CIM insider transaction a purchase on the open market?

No, the Form 4 indicates the shares were acquired at a price of $0 in connection with vesting of equity awards, rather than an open-market purchase.